SCHEMBL31451035

SCHEMBL31451035

CC(C)(C)OC(=O)c1ccc(N2CCC(C(O[Si](C)(C)C(C)(C)C)c3cc(C(=O)O)ccc3-c3ccc(Cl)cc3)CC2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
GPR119 Q8TDV5 3/20 0.34
CNR1 P21554 5/20 0.34
CNR2 P34972 4/20 0.34
BCL2 P10415 3/20 0.34
BCL2L1 Q07817 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
USP2 O75604 2/20 0.34
ENPP2 Q13822 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
ALOX5 P09917 1/20 0.34
PDE5A O76074 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26647739 1.00 MEN1 (0.35) MEN1KMT2ALMNARXFP1GPR119
SCHEMBL26648243 0.91 CNR1 (0.35) MEN1KMT2ALMNARXFP1GPR119
SCHEMBL26648660 0.89 MAPT (0.39) MEN1KMT2ALMNAHTTSMN1; SMN2
SCHEMBL26647941 0.89 MAPT (0.39) MEN1KMT2ALMNAHTTSMN1; SMN2
SCHEMBL26647936 0.89 MAPT (0.39) MEN1KMT2ALMNAHTTSMN1; SMN2
SCHEMBL554341 0.86 TP53 (0.39) CNR1CNR2BCL2BCL2L1USP2
SCHEMBL554340 0.86 TP53 (0.39) CNR1CNR2BCL2BCL2L1USP2
SCHEMBL553496 0.85 BCL2 (0.41) BCL2BCL2L1USP2ENPP2TP53
SCHEMBL553495 0.85 BCL2 (0.41) BCL2BCL2L1USP2ENPP2TP53
SCHEMBL31450817 0.85 F10 (0.40) MEN1KMT2ASMN1; SMN2TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522154-A1 BCL-XL/BCL-2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2025-03-19 EP disclosed